Aptamers as potential therapeutic tools for ovarian cancer: Advancements and challenges
W Szymanowski, A Szymanowska, A Bielawska… - Cancers, 2023 - mdpi.com
Simple Summary Aptamers are versatile molecules for cancer treatment. They can be used
to target specific molecules, conjugated to additional nucleic acid moieties or payloads. In …
to target specific molecules, conjugated to additional nucleic acid moieties or payloads. In …
Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells
K Sooda, SJ Allison, FA Javid - Pharmacology Research & …, 2023 - Wiley Online Library
Cannabinoids have been shown to induce anti‐tumor activity in a variety of carcinoma cells
such as breast, prostate, and brain. The aim of the present study is to investigate the anti …
such as breast, prostate, and brain. The aim of the present study is to investigate the anti …
Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissue in evaluating prognosis of elderly breast cancer patients after modified radical …
J Lv, J Zhang, F Wu - Cellular and Molecular Biology, 2024 - cellmolbiol.org
Cellular and Molecular Biology Page 1 254 Cell. Mol. Biol. (ISSN: 1165-158X) 1. Introduction
Modified radical mastectomy (MCM) is the most commonly applied operation for therapy of …
Modified radical mastectomy (MCM) is the most commonly applied operation for therapy of …
Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis
BM Vastrad, CM Vastrad - bioRxiv, 2024 - biorxiv.org
Endometriosis is a common cause of endometrial-type mucosa outside the uterine cavity
with symptoms such as painful periods, chronic pelvic pain, pain with intercourse and …
with symptoms such as painful periods, chronic pelvic pain, pain with intercourse and …
[PDF][PDF] CDCA2 promotes breast cancer progression by downregulating KISS1 expression
Y Luo, Z Hou, G Feng, D Xiong, J Chen - European Journal of …, 2024 - oss.ejgo.net
Breast cancer is a females' prevalent malignancy, resulting in higher mortality rates than
other cancers. Therefore, exploring effective therapeutic targets and diagnostic biomarkers …
other cancers. Therefore, exploring effective therapeutic targets and diagnostic biomarkers …